Logo
Sunday, 14 April 2024
Friday, 10 Nov 2023 12:00 am

North America Vacuum Blood Collection Tube Market is expected to reach US$ 2,041.98 million by 2030

North America Vacuum Blood Collection Tube Market is growing at a CAGR of 7.3% to reach US$ 2,041.98 million by 2030 from US$ 1,164.83 million in 2022 by Product, Material, Application, End User, and Country.

By The Insight Partners

Serum Separating Tube to Dominate North America Vacuum Blood Collection Tube Market During 2022–2030

According to our new research study on " North America Vacuum Blood Collection Tube Market Size and Forecast (2020–2030), Regional Share, Trend, and Growth Opportunity Analysis," the market value is projected to grow from US$ 1,164.83 million in 2022 to US$ 2,041.98 million by 2030. The vacuum blood collection tube market is further anticipated to record a CAGR of 7.3% from 2022 to 2030. Key factors driving the vacuum blood collection tube market growth are the increasing prevalence of cardiovascular diseases and the burgeoning demand for minimally invasive devices. However, the risk of infection related to vacuum blood collection tubes hinders the market growth.

With increasing awareness and blood donation campaigns and initiatives, several individuals are willingly donating blood, resulting in a high blood donation rate. To ensure a safe blood donation, robust screening processes are carried out to identify potential infections and minimize the risk of disease transmission. These screenings involve the use of vacuum blood collection tubes to collect blood samples from donors for testing. Donor screening tests include infectious disease screening (such as HIV, hepatitis, and syphilis) and additional tests specific to blood safety protocols. The increasing importance of blood donor screening drives the demand for vacuum blood collection tubes to collect and transport blood samples for testing.

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/brochure/TIPRE00026004

As per the American National Red Cross estimates, each year, more than 6.8 million people donate blood in the US. 13.6 million units of red blood cells and whole blood are collected in the US in a year. Approximately 21 million blood components are transfused each year in the US. Moreover, with the rise of blood disorders, the requirement for blood and blood testing is increasing. For instance, about 1,000 babies are born with sickle cell disease each year, and it affects 90,000 to 100,000 people in the US. Sickle cell patients may require blood transfusions throughout their lives.

Similarly, as per the American Cancer Society estimates, more than 1.9 million people were diagnosed with cancer in 2021, and 608,570 people died due to cancer. It is also reported that 1 in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime in the US. Many of them will need blood, sometimes daily, during their chemotherapy treatment. Thus, according to the American National Red Cross, approximately 36,000 units of red blood cells are needed every day in the US. It is estimated that 111 million US citizens, or 37% of the US population, are eligible blood donors. However, less than 10% of the 37% of eligible blood donors donate annually. The Red Cross provides about 40% of the nation's blood and blood components, all from generous volunteer donors.

The growing blood donation rate and the increasing demand for blood tests drive the demand for vacuum blood collection tubes in North America. These tubes support the collection, storage, transportation, and analysis of blood samples, ensuring the integrity and accuracy of diagnostic testing. The availability of vacuum blood collection tubes is crucial for healthcare providers to effectively conduct blood tests, enhance patient care, and support life-saving transfusions.

Becton Dickinson and Co, Greiner Bio-One International GmbH, Sekisui Chemical Co Ltd, SARSTEDT AG & Co KG, Cardinal Health Inc, McKesson Corp, HemaSource Inc, and Medline Industries LP are among the key companies operating in the vacuum blood collection tube market. The companies have been implementing both organic strategies (such as product launches and product approvals) and inorganic strategies (such as expansions, collaborations, and partnerships) to secure growth in the market. In July 2023, SARSTEDT AG & Co KG launched 360 solutions that will be used to improve specimen quality, reduce turnaround time, and automate labs of all sizes with customizable modular systems. The company demonstrated S-Monovette and Tempus600 at the AACC Annual Scientific Meeting & Clinical Lab Expo. The conferences have helped in showcasing the specifications of products. 

The report segments the North America vacuum blood collection tube market as follows:

The North America vacuum blood collection tube market, by product, is segmented into heparin tubes, EDTA tubes, glucose tubes, serum separating tubes, ERS tubes, and others. In 2022, the serum-separating tubes segment held the largest share of the market. The EDTA tubes segment is expected to grow at the highest CAGR during 2022–2030. Serum separating tubes (SSTs) are coated with micro silica particles, which induces clotting blood, and the barrier gel effectively separates serum from fibrin and cells while restricting substance exchange between blood cells and serum. During centrifugation, the clot activator (silica particle) speeds up clotting and acts as a barrier gel, separating serum from fibrin and cells. SSTs are commonly used for blood serum biochemistry, immunology, serology, drug testing, etc. Both non-vacuum and vacuum gel and clot activator tubes are available in the market.

Based on material, the North America vacuum blood collection tube market has been segmented into PET, polypropylene, and tempered glass. The PET segment held the largest share of the market in 2022 and is expected to register the highest CAGR during 2022–2030.

Based on application, the North America vacuum blood collection tube market is segmented into blood routine examination, biochemical test, and coagulation testing. The blood routine examination segment held the largest share of the market in 2022, and the biochemical test segment is anticipated to register the highest CAGR in the market during 2022–2030.

Based on end user, the North America vacuum blood collection tube market is segmented into hospitals and clinics, ambulatory surgical centers, pathology labs, and blood banks. The hospitals and clinics segment held the largest share of the market in 2022, and the blood banks segments is anticipated to register the highest CAGR in the market during 2022–2030.

Contact Us
Contact Person: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com


The Insight Partners :    https://www.theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.


Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
© The News and Media Division of The Insight Partners 2024 | All Rights Reserved | Privacy Policy